Vir Biotechnology, Inc. VIR Cash ratio
Cash ratio at other companies
Other financials
Where this comes from
Calculated from Vir Biotechnology, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vir Biotechnology, Inc.'s cash ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vir Biotechnology, Inc.'s cash ratio?
- Vir Biotechnology, Inc. (VIR) reported cash ratio of 3.8× in Q1 2026.
- How has Vir Biotechnology, Inc.'s cash ratio changed year-over-year?
- Vir Biotechnology, Inc.'s cash ratio increased by 43.6% year-over-year, from 2.7× to 3.8×.
- What is the long-term trend for Vir Biotechnology, Inc.'s cash ratio?
- Over 5 years (2020 to 2025), Vir Biotechnology, Inc.'s cash ratio has grown at a -10.0% compound annual growth rate (CAGR), from 4.4× to 2.6×.
- What does cash ratio mean?
- Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.